ebook Munafa Stock Market Course + Intraday & FNO calls  

       

SNY announcements Sanofi announcements and dividends declared NASDAQ

Sanofi Complete list of announcements declared & dividend announcements by Sanofi SNY

Sanofi SNY listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Sanofi SNY

Dr Reddy's to introduce Sanofi's novel drug in India
Dr. Reddy's Laboratories has expanded its partnership with Sanofi Healthcare to introduce Beyfortus, a novel drug preventing lower respiratory tract disease in newborns caused by RSV. Dr. Reddy's will exclusively promote and distribute Beyfortus in India,
Announcement as on 28 April 2025

Muthoot Finance, Sanofi India among 9 stocks going ex-dividend, split next week. Are they on your radar?
A string of companies, including Sanofi India, Schaeffler India, CIE Automotive, and AMI Organics, will be in focus in the coming week as they head toward their record dates for crucial corporate actions such as dividends and stock splits.
Announcement as on 20 April 2025

Sweet Surrender: Sanofi puts star insulin brand Lantus up for sale, eyes Rs 2,000 crore from Indian pharma giants
Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, though a licensing agreement remains a possibility. The asking price has been reduced to ₹2,000 crore due to declining sales and g
Announcement as on 15 April 2025

FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib
If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability accumulation in multiple sclerosis.
Announcement as on 25 March 2025

Sanofi launches Rezurock against chronic Graft-versus-host disease in India
Sanofi Healthcare India has obtained marketing authorization for Rezurock, a drug for treating Chronic graft versus host disease (cGVHD), a condition that occurs after allogeneic stem cell transplants. The drug, approved by USFDA and CDSCO, offers a new tr
Announcement as on 10 February 2025

Announcements by Sanofi first page | Next page | Prev page |

SNY Sanofi current price & indicator signals

Moving Averages for Sanofi

  • 5Day Average: 43.84
  • 12Day Average: 44.79
  • 20Day Average: 45.84
  • 50Day Average: 46.73
  • 100Day Average: 48.13
  • 150Day Average: 48.28
  • 200Day Average: 48.37

SNY Indicators & signals

Indicator MACD (12,26,9)

44.72, 45.69, -0.75
Indicator MACD is in negative zone

Indicator ADX (14)

26.09, 19.1, 32.58
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 43
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SNY Sanofi are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
17 Tue Mar 2026 44.06 44.03 to 44.59 0.18% 0.75 times
16 Mon Mar 2026 43.98 43.79 to 44.16 0.87% 0.56 times
13 Fri Mar 2026 43.60 43.49 to 44.14 -0.07% 0.65 times
12 Thu Mar 2026 43.63 43.62 to 44.32 -0.71% 1.77 times
11 Wed Mar 2026 43.94 43.79 to 44.22 -0.07% 0.64 times
10 Tue Mar 2026 43.97 43.88 to 44.71 -0.86% 0.74 times
09 Mon Mar 2026 44.35 43.34 to 44.46 -0.45% 0.99 times
06 Fri Mar 2026 44.55 44.00 to 44.63 -1% 1.51 times
05 Thu Mar 2026 45.00 44.71 to 45.34 -2.64% 1.05 times
04 Wed Mar 2026 46.22 45.94 to 46.46 -0.54% 1.02 times
03 Tue Mar 2026 46.47 46.00 to 46.87 -2.5% 1.08 times
02 Mon Mar 2026 47.66 47.43 to 48.07 -2.06% 0.93 times

Videos related to: SNY announcements Sanofi announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

SNY announcements Sanofi announcements and dividends declared NASDAQ

 

Back to top